Recombinant MS4A1 (Ibritumomab Biosimilar) 抗体
This anti-MS4A1 (Ibritumomab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting MS4A1 (Ibritumomab Biosimilar) in ELISA. Suitable for 人.
产品编号 ABIN7488261
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant MS4A1 (Ibritumomab Biosimilar) 抗体 (ABIN7488261)
抗原
MS4A1 (Ibritumomab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This MS4A1 (Ibritumomab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Ibritumomab Biosimilar - Anti-MS4A1(CD20,MS4A-1) mAb
-
产品特性
- Antibody Type: Human IgG2A
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- MS4A1 (Ibritumomab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Ibritumomab is a monoclonal antibody directed against the CD20 antigen found on pre-B and mature B lymphocytes (normal and malignant). Ibritumomab binding induces apoptosis in B lymphocytes in vitro. It is combined with the chelator tiuxetan, which acts as a specific chelation site for Yttrium-90 (Y-90). The monoclonal antibody acts as a delivery system to direct the radioactive isotope to the targeted cells, however, binding has been observed in lymphoid cells throughout the body and in lymphoid nodules in organs such as the large and small intestines. beta-emission induces cellular damage through the formation of free radicals (in both target cells and surrounding cells).
抗原
-
You are here:
